Table 1.
HN derivatives |
Sequence |
Effect (Aβ1-43) |
---|---|---|
HN | MAPRGFSCLLLLTSEIDLPVKRRA | 10 μm |
S14G-HN (HNG) | MAPRGFSCLLLLTGEIDLPVKRRA | 10 nm |
C8A-HN (HNA) | MAPRGFSALLLLTSEIDLPVKRRA | NE |
d-Ser14 HN | MAPRGFSCLLLLT(dS)EIDLPVKRRA | 10 nm |
AGA-HNG | MAPAGASCLLLLTGEIDLPVKRRA | 100-300 pm |
AGA-(d-Ser14)HN | MAPAGASCLLLLT(dS)EIDLPVKRRA | 100-300 pm |
AGA-(d-Ser14)HN17 | PAGASCLLLLT(dS)EIDLP | 100 pm |
AGA-(C8R)HNG17 | PAGASRLLLLTGEIDLP | 10 pm |
EF-HN | EFLIVIKSMAPRGFSCLLLLTSEIDLPVKRRA | 100 nm |
EF-HNA | EFLIVIKSMAPRGFSALLLLTSEIDLPVKRRA | NE |
EF-HNG | EFLIVIKSMAPRGFSCLLLLTGEIDLPVKRRA | 1 nm |
EF-AGA-HNG | EFLIVIKSMAPAGASCLLLLTGEIDLPVKRRA | 10 pm |
Colivelin |
SALLRSIPA-PAGASRLLLLTGEIDLP |
100 fm
|
The abbreviated names, sequences, and the potencies of the antagonizing effect of Aβ1-43-mediated neurotoxicity are indicated for each peptide. Effect indicates minimal concentration of each peptide that exerted full neuroprotection. NE, No protective effect.